Rumeysa Bilginer is integrated PhD student in IZTECH, Bioengineering department. She graduated from genetic and bioengineering department at Istanbul University in 2016. Also, she joined a project for exploring new avenue for diagnostic and treatment on Philadelphia Positive and Negative Acute Lymphoplastic Leukemia in Western General Hospital in Scotland by Erasmus intersnship program in 2016. Currently, she is a member of Biomimetics group and working on Development of on-chip disease model for screening of astragenol derived molecules as potent telomerase activator.